Clinical Trial Update: Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic interaction study evaluating how itraconazole or rifampicin affect TY-9591 tablets in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Itraconazole (Itraconazole)
• Rifampicin
• TY-9591 (TY-9591)

Snippet

Sponsor: TYK Medicines, Inc | Conditions: NSCLC | Phase 1 | Status: COMPLETED